A citation-based method for searching scientific literature

Timothy M Miller, Alan Pestronk, William David, Jeffrey Rothstein, Ericka Simpson, Stanley H Appel, Patricia L Andres, Katy Mahoney, Peggy Allred, Katie Alexander, Lyle W Ostrow, David Schoenfeld, Eric A Macklin, Daniel A Norris, Georgios Manousakis, Matthew Crisp, Richard Smith, C Frank Bennett, Kathie M Bishop, Merit E Cudkowicz. Lancet Neurol 2013
Times Cited: 385







List of shared articles



Times cited



Improving clinical trial outcomes in amyotrophic lateral sclerosis.
Matthew C Kiernan, Steve Vucic, Kevin Talbot, Christopher J McDermott, Orla Hardiman, Jeremy M Shefner, Ammar Al-Chalabi, William Huynh, Merit Cudkowicz, Paul Talman,[...]. Nat Rev Neurol 2021
16

Looking backward to move forward: a meta-analysis of stem cell therapy in amyotrophic lateral sclerosis.
Cynthia Morata-Tarifa, Garikoitz Azkona, Jonathan Glass, Letizia Mazzini, Rosario Sanchez-Pernaute. NPJ Regen Med 2021
1

A perspective on therapies for amyotrophic lateral sclerosis: can disease progression be curbed?
Xiaojiao Xu, Dingding Shen, Yining Gao, Qinming Zhou, You Ni, Huanyu Meng, Hongqin Shi, Weidong Le, Shengdi Chen, Sheng Chen. Transl Neurodegener 2021
0

Glial Cells-The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment.
Tereza Filipi, Zuzana Hermanova, Jana Tureckova, Ondrej Vanatko, And Miroslava Anderova. J Clin Med 2020
15

Treatment of a Mouse Model of ALS by In Vivo Base Editing.
Colin K W Lim, Michael Gapinske, Alexandra K Brooks, Wendy S Woods, Jackson E Powell, M Alejandra Zeballos C, Jackson Winter, Pablo Perez-Pinera, Thomas Gaj. Mol Ther 2020
47

The clinical trial landscape in amyotrophic lateral sclerosis-Past, present, and future.
Heike J Wobst, Korrie L Mack, Dean G Brown, Nicholas J Brandon, James Shorter. Med Res Rev 2020
17

Disease-modifying therapies in amyotrophic lateral sclerosis.
Adriano Chiò, Letizia Mazzini, Gabriele Mora. Neuropharmacology 2020
22

Studying ALS: Current Approaches, Effect on Potential Treatment Strategy.
E I Ustyantseva, S P Medvedev, S M Zakian. Adv Exp Med Biol 2020
2

Emerging Drugs for the Treatment of Amyotrophic Lateral Sclerosis: A Focus on Recent Phase 2 Trials.
Andrea Barp, Francesca Gerardi, Andrea Lizio, Valeria Ada Sansone, Christian Lunetta. Expert Opin Emerg Drugs 2020
1

TRICALS: creating a highway toward a cure.
Ruben P A van Eijk, Tessa Kliest, Christopher J McDermott, Kit C B Roes, Philip Van Damme, Adriano Chio, Markus Weber, Caroline Ingre, Philippe Corcia, Mònica Povedano,[...]. Amyotroph Lateral Scler Frontotemporal Degener 2020
7

Rising Stars: Astrocytes as a Therapeutic Target for ALS Disease.
Michal Izrael, Shalom Guy Slutsky, Michel Revel. Front Neurosci 2020
9

Copper-ATSM as a Treatment for ALS: Support from Mutant SOD1 Models and Beyond.
Sara Nikseresht, James B W Hilton, Kai Kysenius, Jeffrey R Liddell, Peter J Crouch. Life (Basel) 2020
3

Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises.
Luke McAlary, Yee Lian Chew, Jeremy Stephen Lum, Nicholas John Geraghty, Justin John Yerbury, Neil R Cashman. Front Cell Neurosci 2020
3

Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials.
Ruben P A van Eijk, Henk-Jan Westeneng, Stavros Nikolakopoulos, Iris E Verhagen, Michael A van Es, Marinus J C Eijkemans, Leonard H van den Berg. Neurology 2019
31